Heights

London, United Kingdom · Founded 2013 · Privately Held (backing)

Producer of smart supplements intended to elevate and extend cognitive performance by nourishing the brain. Heights is based in London, United Kingdom and was founded in 2013. Its last known valuation is $46.5 million. It has raised $16.5 million.

Last price · $/share
—
Implied valuation
$46.5M
Total raised
$16.5M
Last round
—
What is Heights worth?
$46.5Mlast known valuation
Free account
More of Heights with a free account
  • ·The complete investor list: 21 names
  • ·Watch Heights: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Heights funding history

No rounds on record

No funding rounds for Heights are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.

Pro members can request priority coverage with a 48-hour turnaround.

Heights valuation

Heights's last known valuation is $46.5 million. The figure stands until a priced round, a secondary trade or an institutional fund mark prices the stock again.

How Heights's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Heights, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →

Frequently asked about Heights

What is Heights worth?
Heights's last known valuation is $46.5M.
How much has Heights raised?
Heights has raised $16.5M in total funding across its recorded rounds.